Addition of Cribriform and Intraductal Carcinoma Presence to Prostate Biopsy Reporting Strengthens Pretreatment Risk Stratification Using CAPRA and NCCN Tools
- 1 August 2023
- journal article
- research article
- Published by Elsevier in Clinical Genitourinary Cancer
- Vol. 22 (1) , 47-55
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting StudiesEuropean Urology, 2017
- Disease-specific survival of patients with invasive cribriform and intraductal prostate cancer at diagnostic biopsyLaboratory Investigation, 2016
- Limitations of the Cancer of the Prostate Risk Assessment (CAPRA) Prognostic Tool for Prediction of Metastases and Prostate Cancer-specific Mortality in Patients Treated With External Beam Radiation TherapyAmerican Journal of Clinical Oncology, 2016
- Cribriform growth is highly predictive for postoperative metastasis and disease-specific death in Gleason score 7 prostate cancerLaboratory Investigation, 2015
- Prognostic impact of intraductal carcinoma and large cribriform carcinoma architecture after prostatectomy in a contemporary cohortEuropean Journal of Cancer, 2014
- Prognostic value of the CAPRA clinical prediction rule: a systematic review and meta‐analysisBJU International, 2012
- Digital Quantification of Five High-Grade Prostate Cancer Patterns, Including the Cribriform Pattern, and Their Association With Adverse OutcomeAmerican Journal of Clinical Pathology, 2011
- Risk Assessment for Prostate Cancer Metastasis and Mortality at the Time of DiagnosisJNCI: Journal of the National Cancer Institute, 2009
- Validity of the CAPRA Score to Predict Biochemical Recurrence-Free Survival After Radical Prostatectomy. Results From a European Multicenter Survey of 1,296 PatientsJournal of Urology, 2007
- Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significanceLaboratory Investigation, 2006